Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

A “Call for Standards”: A Clinical Collaboration Involving Industry Experts
  • USA - English


News provided by

Specialty MED Training

May 31, 2018, 18:15 ET

Share this article

Share toX

Share this article

Share toX

Specialty MED Training
Specialty MED Training

AVENTURA, Fla. (PRWEB) May 31, 2018 -- Specialty Med Training and PRP Science, leading companies who are working to advance the field of regenerative medicine, are sponsoring a live, interactive lecture on Wednesday, June 13, 2018 from 6-pm to 8-pm at Serendipity Labs, 20807 Biscayne Blvd #100, Aventura, FL 33180. The featured “Call for Clinical Collaboration” will include a multi-specialty panel of expert scientists and physicians recognized as “thought leaders” in Platelet Rich Plasma (PRP).

The expert panel will peel back the layers of confusion and controversary surrounding the use of PRP and arm interested attendees with the expert knowledge necessary to make the best business and clinical decisions for those using or considering adding these treatment options in their practice.

Post this

In the last five (5) years, interest in PRP has exponentially soared, and consumer demand is driving the majority of its popularity. Recent reports show over 60% of Americans age 50+ are pursuing regenerative interventions, with PRP therapies and non-surgical treatment options topping the list.

PRP is derived from harvesting and concentrating a patient’s own blood. Since it is an autologous biologic - derived from the patient’s own blood - its potential to provide a treatment option with a near perfect safety and efficacy profile is unmatched by any drug or surgical procedure. Unfortunately, because it does not require FDA approval, this leaves little room for regulation by the governing medical establishments and has hindered the development of “Standard of Care” guidelines. For this reason, confusion is also soaring, for both the consumer and the clinician.

This unique “Call for Standards” is a result of the confusion in the marketplace. The fact is, not all PRP is equal. Many of the devices being used today to satisfy consumer demands do not even meet the scientific definition of “Platelet Rich Plasma.” In spite of their claims, many are not capable of consistently processing and producing PRP with the necessary cellular components to achieve tissue healing and regeneration.

The expert panel will peel back the layers of confusion and controversary surrounding the use of PRP and arm interested attendees with the expert knowledge necessary to make the best business and clinical decisions for anyone deciding to add these treatment options to their practice offering.

The panelist line-up includes:
Peter A. Everts, PhD, known as the “Father of PRP, has dedicated his career to the research, specifically the scientific study of autologous biologics.
Joseph Banno, MD, board certified urologist, who in over the 30+ years of treating sexual dysfunction in men and women, developed a combined treatment protocol utilizing PRP, shockwave and hormone therapy that has had overwhelming success as a surgical alternative.
Lisa Vuich, MD, anti-aging and regenerative expert and founder of Renew MediSpa in Windham, NH. Dr. Vuich is a member of the Bridging Biosciences advisory board which has developed a trademarked protocol designed to deliver proven therapeutic concentrations of platelets with customized dosing of individual PRP therapy.

The panelists are recognized by their peers as true pioneers - leading the path towards evidence-based medicine and committed to educating practitioners on the science surrounding PRP’s healing potential - while promoting an ethical and responsible approach to new applications harnessing the power of PRP.

Whether you have been using PRP for many years or are new to the experience, it’s important to stay current with the scientific literature that is helping us define and explore the efficacy of PRP and other regenerative treatments.

Entrance fee is $20 and proceeds go towards continued research and the continued study of regenerative therapies utilizing PRP.

Online registration is required and space is limited to the first 25 registrants. Registrants must be practitioners in clinical practice. No selling of any kind will take place during this event.
Specialty MED Training offers hands on 1 and 2-day regenerative combination therapy courses led by a team of board certified medical experts. Physicians work side by side learning advanced scientific techniques utilizing platelet rich plasma, shockwave therapy, imaging and aesthetic applications to enhance providers' medical skill and injection techniques.
Follow Specialty MED Training on Facebook and YouTube.
PRP Science helps physicians provide advanced treatment options using state-of-the art science, devices and medical equipment that are revolutionizing the regenerative medicine industry.
Follow PRP Science on Facebook and YouTube.

Jill Swartz, Specialty MED Training, https://specialtymedtraining.com, +1 561-703-5851, [email protected]

Modal title

PRP Science
PRP Science
PRP Science

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.